Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (44 ops.)
Latest filing published 13 Jul 2026 for PTC Therapeutics, INC., €100k. Read the official filing
Filing timeline
BuySaleNeil Gregory Almstead
Insider track record
Disclosed buys
0
Disclosed sells
44
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Neil Gregory Almstead: trading record in brief
This profile gathers the share dealings of Neil Gregory Almstead in PTC Therapeutics, Inc., where the filings describe the role as senior executive. Between 4 January 2022 and 9 July 2026, the trades on record add up to 68 filings.
The open-market record consists of 44 sales worth €10.8M, with no purchase. No amount is published for 11 filings, which the totals therefore leave out. Other entries cover 6 share grants and 18 option exercises. Since January 2026: no purchases and 27 sales on the market.
On 13 July 2026 came the latest disclosure, an open-market sale for €195k in PTC Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Neil Gregory Almstead
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations68 total
2,464 shares@ US$46.540.0016% mcap0.5% of flowCommon StockSEC:0001578850-26-000023:0
2,464 shares@ US$90.250.0031% mcap0.9% of flowCommon StockSEC:0001578850-26-000023:1
3,956 shares@ US$87.170.0047% mcap2.3% of flowCommon StockSEC:0001578850-26-000021:9
811 shares@ US$38.100.0004% mcap0.2% of flowCommon StockSEC:0001578850-26-000021:0
426 shares@ US$85.280.0005% mcap0.2% of flowCommon StockSEC:0001578850-26-000021:1
385 shares@ US$86.340.0004% mcap0.2% of flowCommon StockSEC:0001578850-26-000021:2
18,876 shares@ US$38.100.0097% mcap4.8% of flowCommon StockSEC:0001578850-26-000021:3
8,786 shares@ US$85.350.010% mcap5.0% of flowCommon StockSEC:0001578850-26-000021:4
10,090 shares@ US$86.320.012% mcap5.8% of flowCommon StockSEC:0001578850-26-000021:5
2,474 shares@ US$39.420.0013% mcap0.6% of flowCommon StockSEC:0001578850-26-000021:6
2,474 shares@ US$87.030.0029% mcap1.4% of flowCommon StockSEC:0001578850-26-000021:7
24,613 shares@ US$39.420.013% mcap6.4% of flowCommon StockSEC:0001578850-26-000021:8
11,369 shares@ US$89.030.014% mcap6.7% of flowCommon StockSEC:0001578850-26-000021:10
9,288 shares@ US$89.440.011% mcap5.5% of flowCommon StockSEC:0001578850-26-000021:11
412 sharesCommon StockSEC:0001578850-26-000019:0
412 sharesCommon StockSEC:0001578850-26-000019:1
7,718 sharesCommon StockSEC:0001578850-26-000019:2
7,718 sharesCommon StockSEC:0001578850-26-000019:3
401 sharesCommon StockSEC:0001578850-26-000017:0
401 sharesCommon StockSEC:0001578850-26-000017:1
4,922 sharesCommon StockSEC:0001578850-26-000017:2
4,922 sharesCommon StockSEC:0001578850-26-000017:3
1,001 sharesCommon StockSEC:0001578850-26-000017:4
582 sharesCommon StockSEC:0001578850-26-000017:5
419 sharesCommon StockSEC:0001578850-26-000017:6
25 of 68 declarations
